Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BAC vs GSK✓SelectedUSD · GSKBAC vs GSK performance historyLatest closeAs of-1.84%11/16
Stock and ETF performance explorer

BAC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.7%
GSK return
+47.4%
Excess return
-25.7%
Maximum drawdown
-46.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.8%-0.1%-1.8%-1.8%
7D-0.9%-1.3%+0.4%-0.7%
30D-2.2%+2.7%-5.0%-2.7%
3M-21.9%+2.7%-24.7%-22.3%
6M+1.7%+3.3%-1.7%+0.9%
YTD-7.5%+6.5%-13.9%-8.7%
1Y-2.8%+10.7%-13.4%-4.6%
3Y+82.2%+64.4%+17.8%+61.9%
All+21.7%+47.4%-25.7%+4.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling